On August 28, 2025, Windtree Therapeutics Inc. held a virtual Special Meeting where stockholders voted on several proposals, including a significant amendment to increase authorized shares from 125 million to 1 billion. Notably, the proposal for a reverse stock split at a ratio between 1-for-2 and 1-for-25 received over 9 million votes in favor.